Commercial Validation

Prove it in your system.

We offer tightly scoped feasibility pilots to evaluate whether engineered ice-binding proteins can improve performance in your specific freeze-thaw workflow, before you commit to larger development programmes.

8–12 weeks £10k–£30k Decision-grade output
What you are buying

A clearer technical and commercial decision.

The pilot is designed to tell you whether the ice-binding protein approach is worth advancing in your workflow — not to lock you into a broad platform commitment too early.

  • Defined scope around one workflow, one material type, and one meaningful performance question
  • Computational pre-screening through Cryo-Dock before wet-lab evaluation begins
  • Measured evidence that supports a go / no-go recommendation
The Problem Many novel cryobiology propositions ask for large commitments before showing practical workflow relevance.
The Pilot Model A defined, contained engagement designed to generate decision-grade evidence quickly.
The Outcome Clear data to support continued development, formulation work, or early discontinuation.
Pilot Structure

A commercial-first pathway from design to evaluation.

Each pilot is structured to generate practical data under relevant conditions, without requiring long-term platform lock-in or open-ended exploratory work.

How the pilot works

We move from workflow definition to candidate evaluation through a contained sequence designed to reduce uncertainty while keeping scope aligned to a real preservation problem.

1
Discovery and scoping

We define the exact failure point in your workflow, the biological material involved, and the performance endpoints that matter technically and commercially.

2
Digital pre-screening with Cryo-Dock

Before wet-lab work begins, Cryo-Dock is used to model protein–ice interactions and support candidate prioritisation, reducing wasted effort and unnecessary experimental breadth.

3
Wet-lab evaluation

Selected candidates are produced and tested in the context of your specific system and relevant freeze-thaw conditions.

4
Decision-grade recommendation

The pilot concludes with a grounded recommendation on whether the approach merits further development, optimisation, or discontinuation.

Indicative Engagement

8–12 Week Feasibility Pilot

£10k – £30k

Indicative range depending on workflow complexity, assay requirements, and testing scope.

Commercial-first evaluation, not open-ended academic exploration.

Measured outcome data Empirical evidence on post-thaw viability, recovery, stability, or another designated performance endpoint.
Workflow compatibility assessment An initial evaluation of technical fit with your current cryoprotectant formulation, handling, and process logic.
Go / no-go recommendation A commercially useful next-step view based strictly on observed data and real workflow relevance.
Request Pilot Details
Why This Works

Lower adoption friction without diluting technical rigour.

The pilot model is designed to make a complex cryobiology proposition easier to evaluate internally, while still producing output that is technically meaningful.

1

Low-friction first step

A clearly defined engagement is easier for technical and commercial teams to assess than a broad platform proposal requiring a large upfront commitment.

2

Pre-screened efficiency

Digital prioritisation through Cryo-Dock helps focus wet-lab work around candidates most likely to justify experimental attention.

3

Decision-oriented output

The purpose is not simply to generate data, but to support a better technical and commercial decision about what happens next.

Strategic Value

A credible wedge into a difficult technical category.

Cryobiology is a complex set of variables, and many organisations hesitate to adopt new preservation approaches because the perceived risk of workflow disruption is too high.

The feasibility pilot is designed to lower that barrier. By isolating a defined preservation problem and evaluating interfacial ice control within a contained parameter space, technical teams can assess real-world relevance before broader internal approval is required.

Compared with typical innovation offers

Typical early-stage offer

Broad platform promise, unclear entry point, limited workflow specificity, and a high burden of internal justification before any evidence exists.

The IBP Ventures pilot

Defined scope, real workflow relevance, contained budget, and decision-grade evidence that can support or disqualify further work quickly.

Start the Conversation

Let’s scope your pilot.

Tell us where viability loss, recovery issues, or freeze-related instability occur in your process.

We will provide an honest view on whether a feasibility pilot is likely to be a sensible next step for your specific workflow.

Best suited for Clinics, therapy developers, preservation teams, and technical organisations with a defined freeze-thaw challenge
What happens first A short discussion to define the workflow constraint, relevant performance question, and whether a pilot is commercially justified
Company IBP Ventures Ltd
Applied Protein Engineering for Cryobiology
York, United Kingdom